The report highlights access gaps for sexual and reproductive health tools, emphasizing the need for affordable, rapid point-of-care diagnostics for gonorrhea due to rising infections and antimicrobial resistance. With over 82 million annual cases, low- and middle-income countries are disproportionately affected, and drug-resistant strains threaten treatment efficacy. The call is made for concerted efforts to address market gaps and incentivize development to combat this growing public health challenge.
Full Article
